semaglutide and heart disease Efficacy safety of in patients with failure with preserved ejection fraction and obesity - Rehman - 2024 - Clinical Cardiology Semaglutide may reduce heart events

Patients with chronic kidney disease should consult healthcare providers before increasing protein intake, and persistent nausea may require dose adjustment or medical review

doi: 10.1210/endocr/bqaa134 23 Deibert P, Konig D, Vitolins MZ, et al

Balram Bhargava, dean at Holy Family Hospital and former director general of the Indian Council of Medical Research (ICMR), "These are wonder drugs and novel inventions, rightly being called 'magic for obesity.' While currently expensive, costs will come down when generic versions become available

The absence of marked hyperglycemia can delay diagnosis and treatment, resulting in potential serious adverse outcomes

If you are ready to take the next step toward a healthier version of yourself, your journey starts with a simple, no-cost step

Gupta will carefully review your medical background and perform the necessary lab tests to determine eligibility